12:00 AM, 22nd Jan 2026
Marksans Pharma Limited has informed the Exchange about schedule of a conference call for analysts and investors on Friday, February 06, 2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2025